Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ray

Showing results (131-140 of 229) with videos related to

Pageof 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2014
The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumorsP A Cassier, A Floquet, N Penel, et al.
British Journal of Cancer|July 1, 2010
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European regionP A Cassier, F Ducimetière, A Lurkin, et al.
Gynecologie, Obstetrique & Fertilite|December 6, 2001
[Standards, options and recommendations for the initial management of patients with malignant ovarian epithelial tumors (abridged version) ]P Kerbrat, C Lhommé, B Fervers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2013
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupS Cousin, J Y Blay, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomasI Ray-Coquard, P Thiesse, D Ranchère-Vince, et al.
Gynecologie, Obstetrique & Fertilite|January 5, 2002
[Standards, options and recommendations for the management and initial care of patients with malignant epithelial ovarian tumors (abridged version)]P Kerbrat, C Lhommé, B Fervers, et al.
British Journal of Cancer|May 18, 2001
Ovarian cancerP Kerbrat, C Lhommé, B Fervers, et al.
British Journal of Cancer|October 10, 2007
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO groupI Ray-Coquard, D Paraiso, J-P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2013
Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET)C R Rossi, A Vecchiato, G Mastrangelo, et al.
Bulletin Du Cancer|May 28, 2010
[Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region]F Ducimetière, A Lurkin, D Ranchère-Vince, et al.
Pageof 23

Showing results (131-140 of 229) with videos related to

Sort By:
Pageof 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2014
The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumorsP A Cassier, A Floquet, N Penel, et al.
British Journal of Cancer|July 1, 2010
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European regionP A Cassier, F Ducimetière, A Lurkin, et al.
Gynecologie, Obstetrique & Fertilite|December 6, 2001
[Standards, options and recommendations for the initial management of patients with malignant ovarian epithelial tumors (abridged version) ]P Kerbrat, C Lhommé, B Fervers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2013
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupS Cousin, J Y Blay, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomasI Ray-Coquard, P Thiesse, D Ranchère-Vince, et al.
Gynecologie, Obstetrique & Fertilite|January 5, 2002
[Standards, options and recommendations for the management and initial care of patients with malignant epithelial ovarian tumors (abridged version)]P Kerbrat, C Lhommé, B Fervers, et al.
British Journal of Cancer|May 18, 2001
Ovarian cancerP Kerbrat, C Lhommé, B Fervers, et al.
British Journal of Cancer|October 10, 2007
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO groupI Ray-Coquard, D Paraiso, J-P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2013
Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET)C R Rossi, A Vecchiato, G Mastrangelo, et al.
Bulletin Du Cancer|May 28, 2010
[Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region]F Ducimetière, A Lurkin, D Ranchère-Vince, et al.
Pageof 23